Skip to main content

Table 2 Comparison of the immunophenotypic markers expression and CBC with clinical parameters in CLL patients

From: Evaluation of immunophenotypic markers and clinico-hematological profile in chronic lymphocytic leukemia: implications for prognosis

Data p value
Rai stage Modified Rai stage Binet stage Splenomegaly Lymphadenopathy
CD38 0.618 0.648 0.108 0.507 0.109
CD25 0.610 0.859 0.874 0.345 0.466
Double-positive CD56/CD117 0.573 0.650 0.558 0.211 0.854
WBC count × 103/μL 0.239 0.274 0.272 0.312 0.195
Platelets × 103/μL < 0.001** < 0.001** < 0.001** 0.001** 0.606
Hemoglobin g/dL < 0.001** < 0.001** < 0.001** 0.007** 0.709
ALC × 103/μL 0.241 0.273 0.261 0.289 0.201
ANC × 103/μL 0.254 0.535 0.907 0.145 0.749
PLR × 103/μL 0.014* 0.024* 0.027* 0.033* 0.311
NLR × 103/μL 0.292 0.115 0.147 0.327 0.354
  1. CLL chronic lymphocytic leukemia, WBC white blood cell, ALC absolute lymphocyte count, ANC absolute neutrophil count, PLR platelet/lymphocyte ratio, NLR neutrophil/lymphocyte ratio
  2. *Indicates statistical significance (p < 0.05)
  3. **Indicates statistical significance (p < 0.01)